16Feb 2023
Aragonite-Based Scaffold Versus Microfractures and Debridement for the Treatment of Knee Chondral and Osteochondral Lesions: Results of a Multicenter Randomized Controlled Trial

Aragonite-Based Scaffold Versus Microfractures and Debridement for the Treatment of Knee Chondral and Osteochondral Lesions: Results of a Multicenter Randomized Controlled Trial

Lesions of the articular cartilage, with or without the involvement of the subchondral bone, are a common cause of pain and dysfunction in the knee. Although several treatment options have been developed, most previous clinical trials examined patients with isolated or focal midsized defects, which rarely represent the condition found in the general population. Instead, cartilage lesions are often associated with mild to moderate osteoarthritic changes. A study compared the clinical and radiographic outcomes of an aragonite-based osteochondral implant with a control group (arthroscopic debridement/microfractures) in patients affected by joint surface lesions of the knee, including those with concurrent mild to moderate osteoarthritis. The implant group showed statistically superior outcomes in the primary and secondary endpoints at each follow-up, with a responder rate of 77.8% compared to 33.6% in the control group. The aragonite-based scaffold was safe and effective in treating chondral and osteochondral lesions in the knee, providing superior outcomes compared to the control group.

  • #orthopaedics

Like

Save

Share